Assertio Holdings (ASRT) Aperçu de l'action
Assertio Holdings, Inc. est une société pharmaceutique qui fournit divers produits aux patients aux États-Unis. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 3/6 |
| Croissance future | 3/6 |
| Performances passées | 0/6 |
| Santé financière | 6/6 |
| Dividendes | 0/6 |
Récompenses
Analyse des risques
Aucun risque n'a été détecté pour ASRT à partir de nos contrôles de risques.
ASRT Community Fair Values
Create NarrativeSee what 29 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Assertio Holdings, Inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$23.46 |
| Plus haut sur 52 semaines | US$23.47 |
| Plus bas sur 52 semaines | US$8.61 |
| Bêta | 0.53 |
| Variation sur 1 mois | 4.27% |
| Variation sur 3 mois | 104.00% |
| Variation sur 1 an | 136.65% |
| Variation sur 3 ans | -74.28% |
| Variation sur 5 ans | -9.60% |
| Évolution depuis l'introduction en bourse | -90.23% |
Nouvelles et mises à jour récentes
Mise à jour du récit • Jun 05
ASRT: Cash Takeover Agreement Will Anchor Future Upside Potential
Assertio Holdings' updated analyst fair value estimate has shifted from $45.00 to $28.00. The change reflects revised assumptions around growth, profitability and discount rate, as analysts respond to the $23.50 per share cash takeover agreement and recent rating and price target moves.
Mise à jour du récit • May 22
ASRT: Zydus Cash Deal And Garda Termination Will Shape 2026 Outlook
Analysts have raised their price expectations for Assertio Holdings to $23.50 per share from $21.80, citing the terminated Garda amendment and the agreed all-cash acquisition by Zydus Worldwide at $23.50 per share as the key drivers of the updated target and valuation inputs. Analyst Commentary Recent research has highlighted a split in sentiment around Assertio Holdings, even as the all cash acquisition price has become the main reference point for valuation.
Mise à jour du récit • May 03
ASRT: Takeover Agreement And CVR Structure Will Support Future Repricing Potential
Narrative Update on Assertio Holdings The latest analyst price target for Assertio Holdings has been revised to $21.33. Analysts cite the recent downgrades following the takeover agreement as the key factor behind their updated view.Mise à jour du récit • Apr 19
ASRT: Takeover Agreement Will Support Earnings Power And Rerating Potential
Analysts have adjusted Assertio Holdings' price target from about $37.44 to roughly $21.33, reflecting updated views on softer revenue growth, slightly lower profit margins, and a reduced future P/E assumption following recent downgrades related to its takeover agreement. Analyst Commentary Recent research around Assertio Holdings has centered on its takeover agreement and what that means for execution risk, profit quality, and where the shares should trade relative to prior expectations.Recent updates
Mise à jour du récit • Jun 05
ASRT: Cash Takeover Agreement Will Anchor Future Upside Potential
Assertio Holdings' updated analyst fair value estimate has shifted from $45.00 to $28.00. The change reflects revised assumptions around growth, profitability and discount rate, as analysts respond to the $23.50 per share cash takeover agreement and recent rating and price target moves.Mise à jour du récit • May 22
ASRT: Zydus Cash Deal And Garda Termination Will Shape 2026 Outlook
Analysts have raised their price expectations for Assertio Holdings to $23.50 per share from $21.80, citing the terminated Garda amendment and the agreed all-cash acquisition by Zydus Worldwide at $23.50 per share as the key drivers of the updated target and valuation inputs. Analyst Commentary Recent research has highlighted a split in sentiment around Assertio Holdings, even as the all cash acquisition price has become the main reference point for valuation.Mise à jour du récit • May 03
ASRT: Takeover Agreement And CVR Structure Will Support Future Repricing Potential
Narrative Update on Assertio Holdings The latest analyst price target for Assertio Holdings has been revised to $21.33. Analysts cite the recent downgrades following the takeover agreement as the key factor behind their updated view.Mise à jour du récit • Apr 19
ASRT: Takeover Agreement Will Support Earnings Power And Rerating Potential
Analysts have adjusted Assertio Holdings' price target from about $37.44 to roughly $21.33, reflecting updated views on softer revenue growth, slightly lower profit margins, and a reduced future P/E assumption following recent downgrades related to its takeover agreement. Analyst Commentary Recent research around Assertio Holdings has centered on its takeover agreement and what that means for execution risk, profit quality, and where the shares should trade relative to prior expectations.Mise à jour du récit • Apr 04
ASRT: Reverse Split And 2026 Guidance Will Shape Future Upside Potential
Analysts have kept Assertio Holdings' fair value estimate steady at $28.00, while modestly refining their assumptions around revenue growth, profit margins, and future P/E. This has led to a recalibrated price target that they see as better aligned with updated fundamentals.Mise à jour du récit • Mar 21
ASRT: Reverse Split And 2026 Guidance Will Reshape Risk Reward Profile
Analysts have raised their price target on Assertio Holdings from $1.75 to $28.00, citing updated assumptions for revenue growth, profit margins, discount rate, and a lower future P/E multiple in their models. Analyst Commentary Even with a sharply higher price target in some models, not all research views point in the same direction for Assertio Holdings.Mise à jour du récit • Mar 07
ASRT: Reverse Split And Earnings Power Will Support Rerating Potential
Analysts have raised their price target on Assertio Holdings, maintaining the figure at $37.44, while citing updated views on fair value, discount rate, revenue growth, profit margin and future P/E as the reasons for the revised assessment. Analyst Commentary Bullish Takeaways Bullish analysts view the reaffirmed $37.44 price target as consistent with their updated fair value work, suggesting the current share price still leaves room for upside if execution tracks their assumptions.Mise à jour du récit • Feb 21
ASRT: Cost Discipline And 15% Margins Will Support Future Upside Potential
Analysts have revised their price target for Assertio Holdings to $45.00. The update reflects slightly adjusted assumptions around discount rate, revenue growth, profit margin and future P/E expectations.Article d’analyse • Feb 07
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Bounce 35% But Its Business Still Trails The Industry
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders would be excited to see that the share price has had a great...Mise à jour du récit • Feb 07
ASRT: Reverse Split And Earnings Visibility Will Reframe Risk Reward Profile
Analysts have modestly adjusted their price target for Assertio Holdings, citing updated views on discount rates, long term revenue trends and sustainable profit margins, along with a slightly higher assumed future P/E multiple. Analyst Commentary Recent Street research on a comparable operator in the transport and infrastructure space, Asur, offers a useful reference point for how analysts are currently weighing valuation against execution risk when traffic and revenue visibility are in focus.Mise à jour du récit • Jan 24
ASRT: Cost Discipline And 15% Margins Will Support Future Upside Potential
Analysts have trimmed their price target on Assertio Holdings to $45.00 from $44.99, reflecting updated assumptions that indicate a smaller revenue decline, higher profit margins near 15%, and a lower future P/E closer to 16x. Analyst Commentary Bullish analysts in the wider market are pointing to companies that maintain or improve profitability targets and trade on mid-teens P/E multiples as potential opportunities for re-rating when execution holds up.Mise à jour du récit • Jan 10
ASRT: Reverse Split And New Leadership Will Reframe Risk Reward Profile
Analysts lifted their fair value estimate for Assertio Holdings from $2.69 to $37.44, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E as the key drivers of the new price target range. Analyst Commentary Recent Street research on airport operators with similar business profiles offers some context for how analysts might be thinking about Assertio Holdings, particularly around traffic trends, valuation ranges, and the balance between upside potential and execution risk.Mise à jour du récit • Dec 26
ASRT Will Rely On Cost Discipline To Support Future Upside Potential
Analysts have raised their price target on Assertio Holdings significantly, from approximately $3.00 to about $45.00. This reflects a higher assumed fair value multiple despite more conservative expectations for revenue growth and profit margins.Article d’analyse • Dec 24
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Lagging The Industry But So Is The Business
Assertio Holdings, Inc.'s ( NASDAQ:ASRT ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a strong buy...Article d’analyse • Sep 18
Is Assertio Holdings (NASDAQ:ASRT) Using Debt In A Risky Way?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Article d’analyse • May 15
Assertio Holdings, Inc. (NASDAQ:ASRT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Assertio Holdings, Inc. ( NASDAQ:ASRT ) missed earnings with its latest first-quarter results, disappointing...Article d’analyse • Apr 30
Is Assertio Holdings (NASDAQ:ASRT) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Nouveau récit • Apr 28
Rolvedon And Sympazan Will Create New Market Opportunities
Strategic market penetration and increased commercial efforts for Rolvedon and Sympazan aim to boost revenue growth.Article d’analyse • Mar 14
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues Are Not Doing Enough For Some Investors
Assertio Holdings, Inc.'s ( NASDAQ:ASRT ) price-to-sales (or "P/S") ratio of 0.6x might make it look like a strong buy...Article d’analyse • Dec 24
Is Assertio Holdings (NASDAQ:ASRT) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Article d’analyse • Nov 15
Little Excitement Around Assertio Holdings, Inc.'s (NASDAQ:ASRT) Revenues As Shares Take 25% Pounding
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders that were waiting for something to happen have been dealt a blow...Article d’analyse • Sep 25
Is Assertio Holdings (NASDAQ:ASRT) Using Debt Sensibly?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d’analyse • Aug 19
Assertio Holdings, Inc. (NASDAQ:ASRT) Not Doing Enough For Some Investors As Its Shares Slump 30%
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have retraced a considerable 30% in the last month, reversing a fair...Article d’analyse • Jul 04
There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 36% Share Price Rise
Despite an already strong run, Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have been powering on, with a gain of 36...Article d’analyse • May 07
Assertio Holdings, Inc. (NASDAQ:ASRT) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Despite an already strong run, Assertio Holdings, Inc. ( NASDAQ:ASRT ) shares have been powering on, with a gain of 29...Article d’analyse • Apr 18
Does Assertio Holdings (NASDAQ:ASRT) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Article d’analyse • Mar 13
Improved Revenues Required Before Assertio Holdings, Inc. (NASDAQ:ASRT) Stock's 26% Jump Looks Justified
Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders are no doubt pleased to see that the share price has bounced 26...Rendement pour les actionnaires
| ASRT | US Pharmaceuticals | US Marché | |
|---|---|---|---|
| 7D | 0.04% | 5.6% | -3.3% |
| 1Y | 136.6% | 37.6% | 22.3% |
Rendement vs Industrie: ASRT a dépassé le secteur US Pharmaceuticals qui a rapporté 37.6 % au cours de l'année écoulée.
Rendement vs marché: ASRT a dépassé le marché US qui a rapporté 22.3 % au cours de l'année écoulée.
Volatilité des prix
| ASRT volatility | |
|---|---|
| ASRT Average Weekly Movement | 8.9% |
| Pharmaceuticals Industry Average Movement | 10.1% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.1% |
Cours de l'action stable: ASRT n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.
Volatilité au fil du temps: La volatilité hebdomadaire de ASRT ( 9% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 2020 | 53 | Mark L. Reisenauer | www.assertiotx.com |
Assertio Holdings, Inc. est une société pharmaceutique qui fournit divers produits aux patients aux États-Unis. Ses produits pharmaceutiques comprennent INDOCIN, une solution orale et suppositoire pour le traitement de la polyarthrite rhumatoïde modérée à sévère, y compris les poussées aiguës de la maladie chronique, de la spondylarthrite ankylosante et de l'arthrose, ainsi que de l'épaule douloureuse aiguë et de l'arthrite goutteuse. Elle propose également Sympazan, une benzodiazépine pour le traitement d'appoint des crises liées au syndrome de Lennox-Gastaut chez les patients âgés de deux ans ou plus ; CAMBIA, un anti-inflammatoire non stéroïdien (AINS) pour le traitement de la migraine, des nausées, de la photophobie et de la phonophobie ; SPRIX, un AINS pour le traitement à court terme de la douleur modérée à modérément sévère qui nécessite une analgésie au niveau opioïde ; et ROLVEDON, un facteur de stimulation des colonies de granulocytes à action prolongée qui est indiqué pour réduire l'incidence de l'infection causée par la neutropénie fébrile.
Assertio Holdings, Inc. Résumé des fondamentaux
| ASRT statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$151.41m |
| Bénéfices(TTM) | -US$35.69m |
| Recettes(TTM) | US$102.16m |
1.5x
Ratio P/S-4.2x
Ratio P/ELe site ASRT est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| ASRT compte de résultat (TTM) | |
|---|---|
| Recettes | US$102.16m |
| Coût des recettes | US$30.31m |
| Marge brute | US$71.85m |
| Autres dépenses | US$107.54m |
| Les revenus | -US$35.69m |
Derniers bénéfices déclarés
Mar 31, 2026
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | -5.52 |
| Marge brute | 70.33% |
| Marge bénéficiaire nette | -34.94% |
| Ratio dettes/capitaux propres | 51.9% |
Quelles ont été les performances à long terme de ASRT?
Voir les performances historiques et les comparaisonsAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/06/09 08:06 |
| Cours de l'action en fin de journée | 2026/06/09 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Assertio Holdings, Inc. est couverte par 18 analystes. 4 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Scott Henry | Alliance Global Partners |
| null null | Argus Research Company |
| Kenneth Trbovich | Brean Capital Historical (Janney Montgomery) |